Peptomyc

Investments

Peptomyc announces new equity financing round led by Aurora Science

Peptomyc is a spin-off from VHIO – the Vall d’Hebron Institute of Oncology – and ICREA – the Catalan Institute of Research and Advanced Studies -, founded in December 2014 in Barcelona, Spain. The company is focused on the development of innovative cell penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment.

This website uses cookies

This Website uses site management and analytics cookies you can further check our cookies policy here and read here how we process your data and how to exercise your rights.
Accept Read More

The below list details the cookies used in our website.

Cookie	Type	Duration	Description
__cfduid	third party	1 year	Used by the contentn etwork, Cloudflare, to identify trusted web traffic.
_ga	third party	2 years	Registers a uniqu e ID that is used to generate statistical data on how the visitor uses the website.
woocommerce_cart_hash	session	session	e-Commerce temporary session
woocommerce_items_in_cart	session	session	e-Commerce temporary session
wp_woocommerce_session_	session	session	e-Commerce temporary session